SK bioscience said it has applied for emergency use authorization (EUA) for the improved Novavax’s Covid-19 vaccine (NVX-CoV2601), with the Ministry of Food and Drug Safety(MFDS).The updated Novavax Covid-19 vaccine received EUA from the U.S. Food and Drug Administration (FDA) for active immunizatio
The Ministry of Health and Welfare stated that Korea should explore avenues for permitting stem cell treatments beyond the scope of research.The ministry addressed a written query from Rep. Kang Gi-yun of the People Power Party, who raised concerns about South Koreans seeking stem cell therapy abroa
MADRID -- By Kim Chan-hyuk Korea Biomedical Review correspondent -- MSD's anti-PD-1 immuno-oncology drug Keytruda (pembrolizumab) has solidified its position as a first-line treatment with new long-term follow-up results in patients with HER2-positive advanced gastric cancer/gastroesophageal junctio
MADRID -- By Kim Chan-hyuk Korea Biomedical Review correspondent -- The annual congress of the European Society for Medical Oncology (ESMO), Europe's largest cancer society, has been underway in Madrid, Spain, since Friday.As Korean visitors walk through the halls filled with promotional booths for
MADRID -- By Kim Chan-hyuk Korea Biomedical Review correspondent -- The curtain has risen on the European Society for Medical Oncology's Annual Congress (ESMO 2023) at the IFEMA Convention Center in Madrid.ESMO is the largest cancer society in Europe and one of the top three cancer societies in the
JW Pharmaceutical said last Friday it had received notification from LEO Pharma of its intention to return the rights for LEO 152020, a substance aimed at treating atopic dermatitis. LEO 152020 is also known as JW 1601 in Korea. LEO Pharma, a multinational pharma based in Denmark, returned the right
Curocell announced that it has concluded the phase 2 clinical trials of its CAR-T (chimeric antigen receptor-T) drug, Anbal-cel, for treating diffuse large B-cell lymphoma (DLBCL) as it recently completed administering the treatment to the final patient.Speaking at a press conference on Friday notif
Thanks to advances in treatment, the five-year survival rate for breast cancer is now 93.8 percent. The development of treatment techniques in each field, such as surgery, chemotherapy, hormone therapy, and radiation therapy, has reduced the side effects of treatment.However, patients cannot be comp
Premier Partners has been chosen as the manager of the K-Bio and Vaccine 2nd Fund.The Ministry of Health and Welfare said Friday that it has selected Premier Partners as the lead manager of the K-Bio and Vaccine Fund No. 2 and will proceed with the priority formation process for the currently raised
The mandatory installation of CCTVs in operating rooms has been implemented, but experts point out that they might become “useless.”During the National Assembly’s audit of the Ministry of Health and Welfare on Thursday, Rep. Cho Myung-hee of the People Power Party pointed out that CCTVs in operating
Korean pharmaceutical companies are preparing to have a significant impact at this year's CPhI 2023 event, taking place in Barcelona, Spain, from Oct. 24 to 26.CPhI, the world's largest pharma-bio event, annually travels to major European countries. It serves as a crucial platform for global busines
Starting in 2024, Korea will sit on the World Health Organization (WHO) Executive Board to co-initiate international health strategies and responses to global health issues.The Ministry of Health and Welfare said Friday that Korea was nominated as one of the two countries to serve on the WHO Executi
"Reasons are aplenty for biopharmaceutical companies to invest in Uijeongbu. For instance, the city's proximity to Seoul makes it easy to attract high-quality human resources, the presence of university hospitals nearby facilitates the conduct of clinical trials, and the ability to purchase large pa
Geo-Young, South Korea's largest pharmaceutical distributor, has categorically denied recent speculations about a possible acquisition by Zuellig Pharma, as reported by multiple news sources.Geo-Young refuted rumors suggesting that Zuellig Pharma may be seeking to purchase the company from Blackston
Korea's alarming stomach cancer rates have long been a concern. In 2019, this disease accounted for 11.6 percent of all cancer cases, with 29,493 new diagnoses.A recent study shed light on the key risk factors associated with stomach cancer, highlighting physical inactivity as the most prevalent amo
A recent state audit has revealed that doctors and nurses in Korea can retain their medical licenses even if they struggle with drug addiction.Moreover, there have been confirmed instances of doctors who, despite losing their licenses, continue to practice and prescribe non-insured drugs, prompting
Kakao Healthcare said it has entered into a business partnership with C&R Research, the country's first contract research organization (CRO), to conduct global clinical trials jointly.The partnership will combine the medical big data platform and artificial intelligence technologies of Kakao Healthc
Gilead recently launched the first Trop-2-targeted antibody-drug conjugate (ADC), Trodelvy (sacituzumab govitecan), in Korea, providing a new treatment option for patients with metastatic triple-negative breast cancer who have limited options.Gilead began the domestic supply of Trodelvy on Wednesday
AstraZeneca's Soliris (eculizumab) has demonstrated its long-term efficacy and safety profile in a real-world study in Korean patients with paroxysmal nocturnal hemoglobinuria (PNH).The October issue of the Journal of Korean Medical Science, an international medical journal of the Korean Medical Ass
The entire nation is buzzing about the expansion of the medical school enrollment quota.No one knows how many medical school students will be added or how they will be allocated. Still, private academies are stepping up their "medical school marketing," and localities have joined the race to secure